Published in Med Pediatr Oncol on December 01, 2002
Salivary gland diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg (2014) 0.91
[Malignant epithelial salivary gland tumors. Clinical review of 2 decades]. Mund Kiefer Gesichtschir (2004) 0.85
125I seed implant brachytherapy for the treatment of parotid gland cancers in children and adolescents. Strahlenther Onkol (2013) 0.84
Non-hematological tumors of head and neck region in the pediatric age group in a tertiary care cancer center. Pediatr Surg Int (2011) 0.78
Salivary gland tumors in Turkey: demographic features and histopathological distribution of 510 patients. Indian J Otolaryngol Head Neck Surg (2012) 0.77
Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer (2005) 3.27
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79
Cytokeratin expression in central mucoepidermoid carcinoma and glandular odontogenic cyst. Oral Oncol (2004) 1.69
Pectoralis major and other myofascial/myocutaneous flaps in head and neck cancer reconstruction: experience with 437 cases at a single institution. Head Neck (2004) 1.66
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. J Clin Oncol (2006) 1.57
Comparison of two prognostic scores for patients with parotid carcinoma. Head Neck (2009) 1.55
Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res (2005) 1.47
Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol (2010) 1.46
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med (2009) 1.42
Oral myofibromas: report of two cases and review of clinical and histopathologic differential diagnosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 1.30
Cutaneous angiosarcoma of the head and neck: report of 23 cases from a single institution. Otolaryngol Head Neck Surg (2008) 1.28
Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg (2004) 1.23
Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer. Head Neck (2010) 1.22
Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol (2005) 1.22
Risk factors for stomach cancer in Brazil (I): a case-control study among non-Japanese Brazilians in São Paulo. Jpn J Clin Oncol (2002) 1.22
Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases. Int J Pediatr Otorhinolaryngol (2004) 1.21
Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas. Oral Oncol (2003) 1.21
Surgical complications after thyroid surgery performed in a cancer hospital. Otolaryngol Head Neck Surg (2005) 1.20
Oral verrucous carcinoma: a retrospective study in São Paulo Region, Brazil. Clin Oral Investig (2006) 1.20
Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol (2004) 1.20
Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg (2003) 1.19
Risk factors for stomach cancer in Brazil (II): a case-control study among Japanese Brazilians in São Paulo. Jpn J Clin Oncol (2002) 1.19
Giant pleomorphic adenoma of the parotid gland. Med Oral Patol Oral Cir Bucal (2008) 1.13
Extraocular retinoblastoma: a 13-year experience. Cancer (2003) 1.11
A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol (2006) 1.11
Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol (2007) 1.11
Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J Can Dent Assoc (2007) 1.11
Predictive factors and distribution of lymph node metastasis in lip cancer patients and their implications on the treatment of the neck. Oral Oncol (2004) 1.09
[Delayed diagnosis in retinoblastoma]. J Pediatr (Rio J) (2004) 1.09
Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma: a comparison. Arch Otolaryngol Head Neck Surg (2004) 1.09
Adenoid cystic carcinoma and mucoepidermoid carcinoma of the maxillary sinus: report of a 44-year experience of 25 cases from a single institution. J Oral Maxillofac Surg (2006) 1.08
Nonlymphoid mesenchymal tumors of the parotid gland. Oral Oncol (2008) 1.07
Clinical predictors of quality of life in patients with initial differentiated thyroid cancers. Arch Otolaryngol Head Neck Surg (2009) 1.04
Multiple granular cell tumors of the tongue and parotid gland. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 1.04
Rhabdomyosarcoma of the head and neck: a clinicopathological and immunohistochemical analysis of 29 cases. Braz Dent J (2010) 1.02
Plasmacytoid myoepithelioma of the palate in a child. Int J Paediatr Dent (2007) 1.01
Tissue eosinophilia and its association with tumoral invasion of oral cancer. Int J Surg Pathol (2009) 1.00
HOXA1 is overexpressed in oral squamous cell carcinomas and its expression is correlated with poor prognosis. BMC Cancer (2012) 0.99
Papillary squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg (2009) 0.98
Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck (2006) 0.97
Perioperative complications, comorbidities, and survival in oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg (2003) 0.97
Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91. J Clin Oncol (2009) 0.97
Quality of life related to swallowing after tongue cancer treatment. Dysphagia (2007) 0.97
Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas. Oral Oncol (2009) 0.97
Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group. Pediatr Blood Cancer (2010) 0.97
Bilateral renal metastases from osteosarcoma: A case report and review of the literature. J Pediatr Hematol Oncol (2006) 0.96
The role of eosinophils and eosinophil cationic protein in oral cancer: a review. Arch Oral Biol (2010) 0.96
Trends in childhood leukemia mortality in Brazil and correlation with social inequalities. Cancer (2007) 0.96
Voice and vocal self-assessment after thyroidectomy. Head Neck (2006) 0.96
Treatment of relapsed Wilms tumors: lessons learned. Expert Rev Anticancer Ther (2009) 0.95
CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients. Oral Oncol (2009) 0.95
Postoperative complications of thyroidectomy for differentiated thyroid carcinoma. Am J Otolaryngol (2004) 0.94
Distribution of metastatic lymph nodes in oropharyngeal carcinoma and its implications for the elective treatment of the neck. Arch Otolaryngol Head Neck Surg (2003) 0.93
Recurrent oral cancer: current and emerging therapeutic approaches. Front Pharmacol (2012) 0.93
Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol (2011) 0.93
Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence. Oral Oncol (2006) 0.93
Management of extensive osteoradionecrosis of the mandible with radical resection and immediate microvascular reconstruction. J Oral Maxillofac Surg (2007) 0.92
Distinct regions of loss of heterozygosity on 22q in different sites of head and neck squamous cell carcinomas. Med Sci Monit (2002) 0.92
Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. Br J Clin Pharmacol (2014) 0.92
Surgical treatment of paragangliomas of the carotid bifurcation: results of 36 patients. Head Neck (2004) 0.92
Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg (2008) 0.92
TIMP3 and CCNA1 hypermethylation in HNSCC is associated with an increased incidence of second primary tumors. J Transl Med (2013) 0.92
CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck (2011) 0.92
High-risk human papillomavirus in oral squamous cell carcinoma of young patients. Int J Cancer (2011) 0.92
Prevalence of upper aerodigestive symptoms in patients who underwent thyroidectomy with and without the use of intraoperative laryngeal nerve monitoring. Thyroid (2012) 0.92
Head and neck chondrosarcoma: analysis of 16 cases. Br J Oral Maxillofac Surg (2009) 0.91
For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch (2015) 0.91
Cultural adaptation, translation and validation of a functional outcome questionnaire (TESS) to Portuguese with application to patients with lower extremity osteosarcoma. Pediatr Blood Cancer (2008) 0.91
Computed tomography-guided needle biopsies in pediatric oncology. J Pediatr Surg (2003) 0.90
Comparative cytokeratin expression in the different cell types of salivary gland mucoepidermoid carcinoma. Head Neck Pathol (2008) 0.90
Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country. Arch Otolaryngol Head Neck Surg (2004) 0.90
Dietary patterns and risk of oral cancer: a case-control study in São Paulo, Brazil. Rev Saude Publica (2007) 0.90
Use of amifostine in the therapy of osteosarcoma in children and adolescents. J Pediatr Hematol Oncol (2002) 0.90
Candida oral colonization and infection in Brazilian patients undergoing head and neck radiotherapy: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 0.90
Noninvasive ventilation in immunocompromised pediatric patients: eight years of experience in a pediatric oncology intensive care unit. J Pediatr Hematol Oncol (2008) 0.90
Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. Cancer Causes Control (2014) 0.89
Validation of the Washington University Head and Neck Comorbidity Index in a cohort of older patients. Arch Otolaryngol Head Neck Surg (2008) 0.89
Childhood leukemia incidence in Brazil according to different geographical regions. Pediatr Blood Cancer (2011) 0.89
Identification of upregulated genes in oral squamous cell carcinomas. Head Neck (2012) 0.89
Parotid neoplasms: analysis of 600 patients attended at a single institution. Braz J Otorhinolaryngol (2009) 0.88
Brazilian-Portuguese validation of the University of Washington Quality of Life Questionnaire for patients with head and neck cancer. Head Neck (2006) 0.88
Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope (2007) 0.88
TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer (2013) 0.88
Estrogen receptor expression in salivary gland mucoepidermoid carcinoma and adenoid cystic carcinoma. Pathol Oncol Res (2004) 0.88
HOXB7 expression is a prognostic factor for oral squamous cell carcinoma. Histopathology (2012) 0.88
Validation and application of the M.D. Anderson Dysphagia Inventory in patients treated for head and neck cancer in Brazil. Dysphagia (2012) 0.87
Biological markers and prognosis in recurrent oral cancer after salvage surgery. Arch Otolaryngol Head Neck Surg (2008) 0.87
Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Carcinogenesis (2012) 0.86
Second primary tumors in patients with head and neck cancer. Curr Oncol Rep (2011) 0.86
Clinicopathologic and immunohistochemical study of intraoral mucoepidermoid carcinoma. Otolaryngol Head Neck Surg (2006) 0.86
Molecular profiling of isolated histological components of wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development. Oncology (2008) 0.86
Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clin Exp Metastasis (2014) 0.86
Caspase expression in oral squamous cell carcinoma. Head Neck (2010) 0.86
APACHE II, POSSUM, and ASA scores and the risk of perioperative complications in patients with oral or oropharyngeal cancer. Arch Otolaryngol Head Neck Surg (2003) 0.86
Mammary analogue secretory carcinoma of salivary glands is a lipid-rich tumour, and adipophilin can be valuable in its identification. Histopathology (2013) 0.86
Nucleophosmin, p53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray. Hum Pathol (2010) 0.85
Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma. Histopathology (2010) 0.85
Metastatic renal cell carcinoma to the oral cavity and clear cell mucoepidermoid carcinoma: comparative clinicopathologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.85
Methotrexate for high-grade osteosarcoma in children and young adults. Cochrane Database Syst Rev (2011) 0.84
Immunoexpression of Ezrin and CD44 in patients with osteosarcoma. J Pediatr Hematol Oncol (2010) 0.84